Category Archives: Vascular Biology

The sightings have been noted since early in the pandemic critters everywhere, including here in Connecticut. Continue reading →

New hires and promotions in the metro Augusta area. Frank Kassner Employer: Edgars Hospitality Group Title: Executive Chef and Culinary Operations Director Responsibilities: Oversee culinary operations at Edgars Grille, The Pinnacle Club, Edgars Above Broad, Snelling Conference Center, Anderson Conference Center, Edgars Catering & Events and contract food service division Experience: Was previously executive chef at Montage Palmetto Bluff in Bluffton, S.C.; served 17 years with The Ritz-Carlton hotel brand in Boston and at Florida properties in Naples, Amelia Island and Sarasota Dr Continue reading →

Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones Continue reading →

It was a few hours after the arrival of the container40 feet long, straight from Hong Kong and dense with the McCullough familys earthly possessionsthat the sneezing fits returned. So instead of reveling in unpacking and arranging in the way only a decorator amid a trans-global relocation could, Lucie McCullough embarked down a rabbit hole to find some answers about why her body seemed at odds with her environment Continue reading →

University of Maryland researchers discovered a new role for a well-known plant molecule called ACC, providing the first clear example of this molecule acting as a likely plant hormone. In their new publication in Nature Communications, researchers present findings that could help rewrite textbooks, translating to practical applications for plant reproduction and improved crop yield. COLLEGE PARK, Md., Aug.14, 2020 /PRNewswire-PRWeb/ -- Researchers at the University of Maryland (UMD) have discovered an entirely new role for a well-known plant molecule called ACC, providing the first clear example of ACC acting on its own as a likely plant hormone Continue reading →

MENLO PARK Aug 14, 2020 (Thomson StreetEvents) -- Edited Transcript of CohBar Inc earnings conference call or presentation Thursday, August 13, 2020 at 9:00:00pm GMT CohBar, Inc. - CFO, Treasurer & Secretary CohBar, Inc Continue reading →

According to the latest market report published by PMR on thegrowth factors marketduring2014 2018and forecast for2019 2029,the global growth factors market is projected to reach~ US$ 2.5 Bn by the end of 2029.The growth factors market is expected to grow with a CAGR of~ 8 %during the forecast period2019-2029. Growth factors are gaining high demand for cell culture-based research in the field of oncology, wound management, cardiovascular, and other medical fields. Continue reading →

New York [US], July 4 (ANI): Retinal vein occlusion which is a major cause of blindness for millions of adults worldwide can be prevented with a new eye drops solution developed by a team of researchers. A study, in mice, suggests that the experimental therapy, which targets a common cause of neurodegeneration and vascular leakage in the eye, could have broader therapeutic effects than existing drugs. Continue reading →

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- jCyteInc., a biotech company dedicated to improving the lives of patients with rare degenerative retinal diseases, announced today its Scientific Advisory Board (SAB) comprised of world-renowned retinal physicians to provide external scientific review and high-level counsel on the Companys research and development programs. The SAB will continue to work closely with the jCyte leadership team, as the Company advances the clinical development of its investigational drug candidate jCell, a first-in-class investigational treatment for retinitis pigmentosa, an inherited retinal disease Continue reading →

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte Inc., a biotech company dedicated to improving the lives of patients with rare degenerative retinal diseases, announced today its Scientific Advisory Board (SAB) comprised of world-renowned retinal physicians to provide external scientific review and high-level counsel on the Companys research and development programs. The SAB will continue to work closely with the jCyte leadership team, as the Company advances the clinical development of its investigational drug candidate jCell, a first-in-class investigational treatment for retinitis pigmentosa, an inherited retinal disease. Continue reading →